Cancer eNews - 6 Nov 2020

Were you sent this newsletter by a colleague and want to be added to our list? Subscribe here.

The Cancer Clinical Academic Group is now proudly working with Translational Cancer Research Centre partners to bring you the latest news, grant opportunities, and events from our combined network

Uniting cancer research into a globally-leading partnership to deliver continuing evidence-based practice in diagnosis, intervention, and support

Express your interest in leading the Cancer CAG - deadline extended

Scientia Professor Michael Barton will be stepping down as the Director of the Cancer CAG in mid-2021. Expressions of interest are sought for the role. The appointed Director will lead preparation of a Cancer Institute NSW grant application that will form the basis of the next 5 years of activity. Please see the EOI form for further information and submit for consideration ASAP.

EOI

Recent articles - TCRN members

A monthly list of some recent peer-reviewed articles from TCRN members.

GRANTS

Cancer CAG E/MCR Seed grants

Four grants are available to early or mid-career researchers. Projects can address any area along the continuum of cancer control and must have direct relevance to at least one Cancer BIG Idea. The funds for these collaborative grants are sourced from Cancer CAG and SPHERE funds, as well as additional UNSW philanthropic funds administered by UNSW Sydney.

Four grants of up to $50,000 over 1 year are available to undertake projects in at least one of the priority areas.
Two of the four grants will be awarded to UNSW affiliated researchers for projects focussing on low grade gliomas.

Further detail is provided in the application form and information from Dr Rebekah Puls.

Deadline: 6 December 2020

Ian Potter Foundation - Medical Research

Grants are available for the provision of equipment and capital infrastructure to support outstanding medical research groups. Min. funding of $100K is available for institutions and organisations, with a maximum of two application submissions per organisation in a given grant round.

Deadline: 22 January 2021

MRFF Funding Opportunities

2021 Frontier Health and Medical Research Initiative Deadline: 11 Dec 2020
2020 Childhood Cancer Research Grant Opportunity Deadline: 3 Feb 2021
2020 Efficient Use of Existing Medicines Grant Opportunity Deadline: 3 Feb 2021
2020 Primary Health Care Research Data Infrastructure Grant Opportunity Deadline: 23 Feb 2020
2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity Deadline: 23 Feb 2020
2020 International Clinical Trial Collaborations Grant Opportunity Round 2 Deadline: 3 Mar 2021

AWARDS, TRAINING AND RESOURCES

Cancer data in Australia - update

The AIHW Cancer data in Australia report was updated on 30 October. This report presents cancer incidence, mortality, survival, risk and prevalence statistics using data from 1982 to 2016 (2018 for mortality) and projections up to 2020 for cancer incidence and mortality.

The AIATSIS Code

AIATSIS recently published the Code of Ethics for Aboriginal and Torres Strait Islander Research (The AIATSIS Code), which ensures that research with and about Aboriginal and Torres Strait Islander peoples follows a process of meaningful engagement and reciprocity between the researcher and the individuals and/or communities involved in the research.

SEMINARS AND EVENTS

Randwick Precinct Cancer Roundtable - Mucinous Ovarian Cancer

Mucinous Ovarian Cancer Live Stream Workshop presented by Nicki Meagher and facilitated by Prof. Anna deFazio.

When: 10 November 2020

CONCERT Roundtable - Engaging Consumers in Cancer Research

Presented and facilitated by Nicola Straiton, Dr Ben Smith and Derek Cunningham.

When: 11 November 2020

Read more

TCRN Consumer Involvement in Research Information Session and Workshop

Join us for a virtual Consumer Involvement in Research Information Session and Consumer Workshop.Registrations close Wednesday the 11th of November, 2020 COB.

Information Session open to both TCRN and non-TCRN members
Researchers will learn how to involve consumers in their research via a showcase of successful partnerships, answers to FAQs and tips on how.
Consumer Workshop TCRN members only - Limited spots available
This is a valuable opportunity to engage with a group of consumers and present your research plan for their input. Researchers who already have a consumer partner but wish to have group input are also welcome.

When: 17 November 2020

Read more and register

Clinical challenges in wound management workshop

Cancer Symptom Trials (CST) is hosting a Clinical challenges in wound management workshop. The workshop will bring together clinicians, researchers and consumers to consider new study ideas that will generate evidence to enhance clinical management and decision making around malignant wounds.

When: 19 November 2020

Read more

CONCERT T1/T2 Workshop

CONCERT T1/T2 Workshop T1/T2 workshop: Focus on Colorectal Cancer and Head and Neck Cancers – use of biobank resources for clinical translational studies.

When: 20 November 2020

Read more

PaCCSC and CST Annual Research Forum 2021

The online UTS Palliative Population Studies and Cancer Population Studies 2021 Research forum is open for registration. The 2021 theme is Clinical trials in a changing world.

When: 11 - 12 March 2021

ABOUT US

TCRN

The Translational Cancer Research Network (TCRN) is a translational cancer research centre program funded by the Cancer Institute NSW and is a collaborative and interactive cancer research community based in the South East of Sydney, with links to cancer services and researchers in inner and southern Sydney, and Albury. It was formed to create an innovative and supportive environment for the translation of cancer research into improvements in patient care.

CONCERT

The Centre for Oncology Education, Research and Training (CONCERT) is a translational research centre program funded by the Cancer Insitute NSW. CONCERT exists to bring together the knowledge and expertise of cancer health professionals and researchers to facilitate translation of research generated evidence into practice to achieve better outcomes for those affected by cancer.

Cancer CAG

The Cancer Clinical Academic Group (Cancer CAG) brings together clinicians and researchers from three universities, four cancer services (with six major treatment facilities) and three Medical Research Institutes. Our combined research strength spans the translational medicine spectrum of bench to bedside and health service delivery.

Working with TCRC partners, our network extends to all of the organisations below.

Connect with us!

CONCERT

Cancer CAG

TCRN